A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease

Surgery

Volumn 142, Issue 3, 2007, Pages 398-404

  Riss, Philipp ^a   Kaczirek, Klaus ^a   Heinz, George ^b   Bieglmayer, Christian ^b   Niederle, Bruno ^a  

^a Section of Endocrine Surgery   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MULTIPLE GLAND DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PEROPERATIVE CARE; PREDICTOR VARIABLE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCIUM; DIAGNOSTIC TECHNIQUES, ENDOCRINE; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PARATHYROID GLANDS; PARATHYROID HORMONE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REOPERATION; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TIME FACTORS;

EID: 34548133107     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.05.004     Document Type: Article

References (30)

1. Irvin III G.L., Dembrow V.D., and Prudhomme D.L. Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162 (1991) 299-302
2. Prager G., Czerny C., Ofluoglu S., Kurtaran A., Passler C., Kaczirek K., et al. Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg 196 (2003) 541-548
3. Jaskowiak N.T., Sugg S.L., Helke J., Koka M.R., and Kaplan E.L. Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137 (2002) 659-668 discussion 68-9
4. Burkey S.H., Van Heerden J.A., Farley D.R., Thompson G.B., Grant C.S., and Curlee K.J. Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism?. World J Surg 26 (2002) 914-920
5. Vignali E., Picone A., Materazzi G., Steffe S., Berti P., Cianferotti L., et al. A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases. Eur J Endocrinol 146 (2002) 783-788
6. Yang G.P., Levine S., and Weigel R.J. A spike in parathyroid hormone during neck exploration may cause a false-negative intraoperative assay result. Arch Surg 136 (2001) 945-949
7. Carter A.B., and Howanitz P.J. Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 127 (2003) 1424-1442
8. Inabnet W.B., Fulla Y., Richard B., Bonnichon P., Icard P., and Chapuis Y. Unilateral neck exploration under local anesthesia: the approach of choice for asymptomatic primary hyperparathyroidism. Surgery 126 (1999) 1004-1009 discussion 9-10.
9. Thompson G.B., Grant C.S., Perrier N.D., Harman R., Hodgson S.F., Ilstrup D., et al. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg 134 (1999) 699-704 discussion 705
10. Weber K.J., Misra S., Lee J.K., Wilhelm S.W., DeCresce R., and Prinz R.A. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136 (2004) 1154-1159
11. Mortier P.E., Mozzon M.M., Fouquet O.P., Soudan B.C., Huglo D.G., Cussac J.F., et al. Unilateral surgery for hyperparathyroidism: indications, limits, and late results-new philosophy or expensive selection without improvement of surgical results?. World J Surg 28 (2004) 1298-1304
12. Niederle B., Roka R., Woloszczuk W., Klaushofer K., Kovarik J., and Schernthaner G. Successful parathyroidectomy in primary hyperparathyroidism: a clinical follow-up study of 212 consecutive patients. Surgery 102 (1987) 903-909
13. Prager G., Czerny C., Kurtaran A., Passler C., Scheuba C., and Niederle B. [The value of preoperative localization studies in primary hyperparathyroidism]. Chirurg 70 (1999) 1082-1088
14. Prager G., Czerny C., Kurtaran A., Passler C., Scheuba C., Bieglmayer C., et al. Minimally invasive open parathyroidectomy in an endemic goiter area: a prospective study. Arch Surg 136 (2001) 810-816
15. Bieglmayer C., Prager G., and Niederle B. Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem 48 (2002) 1731-1738
16. Woodrum D.T., Saunders B.D., England B.G., Burney R.E., Doherty G.M., and Gauger P.G. The influence of sample site on intraoperative PTH monitoring during parathyroidectomy. Surgery 136 (2004) 1169-1175
17. Carneiro D.M., Solorzano C.C., Nader M.C., Ramirez M., and Irvin III G.L. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?. Surgery 134 (2003) 973-979 discussion 9-81
18. Yen T.W., Wilson S.D., Krzywda E.A., and Sugg S.L. The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery 140 (2006) 665-672 discussion 72-4
19. Riss P., Kaczirek K., Bieglmayer C., and Niederle B. PTH spikes during parathyroid exploration-a possible pitfall during PTH monitoring?. Langenbecks Arch Surg 392 (2007) 427-430
20. Bergenfelz A., Lindblom P., Tibblin S., and Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236 (2002) 543-551
21. Grant C.S., Thompson G., Farley D., and van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140 (2005) 472-478 discussion 8-9
22. Burkey S.H., Snyder III W.H., Nwariaku F., Watumull L., and Mathews D. Directed parathyroidectomy: feasibility and performance in 100 consecutive patients with primary hyperparathyroidism. Arch Surg 138 (2003) 604-608 discussion 8-9
23. Sackett W.R., Barraclough B., Reeve T.S., and Delbridge L.W. Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137 (2002) 1055-1059
24. Sharma J., Mazzaglia P., Milas M., Berber E., Schuster D.M., Halkar R., et al. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality?. Surgery 140 (2006) 856-863 discussion 63-5
25. Chiu B., Sturgeon C., and Angelos P. What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia?. A study of 401 consecutive patients undergoing parathyroidectomy. Surgery 140 (2006) 418-422
26. Sugg S.L., Krzywda E.A., Demeure M.J., and Wilson S.D. Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Surgery 136 (2004) 1303-1309
27. Carneiro-Pla D.M., Solorzano C.C., and Irvin III G.L. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg 202 (2006) 715-722
28. Lepage R., Roy L., Brossard J.H., Rousseau L., Dorais C., Lazure C., et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44 (1998) 805-809
29. Irvin III G.L., Solorzano C.C., and Carneiro D.M. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28 (2004) 1287-1292
30. Gauger P.G., Mullan M.H., Thompson N.W., Doherty G.M., Matz K.A., and England B.G. An alternative analysis of intraoperative parathyroid hormone data may improve the ability to detect multiglandular disease. Arch Surg 139 (2004) 164-169